Research
Christopher's research focuses on translational antimicrobial pharmacology research using a variety on in vitro, in vivo and in silico techniques. Particular expertise is in population pharmacokinetic and physiology-based pharmacokinetic modelling. Particular areas of interest are combination antimicrobials, repurposing older antibiotics and dosing in special populations.
Research grants
Further in vitro and in silico work to support regimen selection for off-patent antibiotics investigated by GARDP (GARDP Adult PK)
GARDP FOUNDATION (SWITZERLAND)
July 2025 - July 2026
Fleming Fund Fellowship Fund
THE FLEMING FUND (UK)
February 2024 - December 2025
Expansion of assessment pharmacodynamics of flomoxef-fosfomycin and fosfomycin/amikacin combinations for neonatal sepsis using the HFIM
GARDP FOUNDATION (SWITZERLAND)
August 2022 - March 2024